-
Herold KC, Bundy BN, Long SA, Bluestone JA, et al.
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes. N Engl J Med 2019.
-
Bjellvi J, Olsson I, Malmgren K, Wilbe Ramsay K, et al.
Epilepsy duration and seizure outcome in epilepsy surgery: A systematic review
and meta-analysis. Neurology 2019.
-
Murray PG, Young LS.
An etiological role for the Epstein-Barr virus in the pathogenesis of classical
Hodgkin lymphoma. Blood 2019.
-
Durcan L, O'Dwyer T, Petri M.
Management strategies and future directions for systemic lupus erythematosus in
adults. Lancet 2019;393:2332-2343.
-
Pratley R, Amod A, Hoff ST, Kadowaki T, et al.
Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes
(PIONEER 4): a randomised, double-blind, phase 3a trial. Lancet 2019.
|